Andrew Schutte
Chief Executive Officer bei REPLICEL LIFE SCIENCES INC.
Vermögen: 779 004 $ am 31.03.2024
Profil
Andrew Schutte is currently the President, Chief Executive Officer & Director at RepliCel Life Sciences, Inc. He is also the President at Nolan Olbohrung, LLC and Valence Oil LLC.
Previously, he served as the Chief Technology Officer at MainPointe Pharmaceuticals LLC from 2016 to 2022.
Prior to that, he worked as a VBA Programmer at Gerimed, Inc. from 2012 to 2016.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPLICEL LIFE SCIENCES INC.
26,77% | 16.08.2023 | 17 401 616 ( 26,77% ) | 765 671 $ | 31.03.2024 |
| 16.08.2023 | 303 030 ( 27,82% ) | 13 333 $ | 31.03.2024 |
Aktive Positionen von Andrew Schutte
| Unternehmen | Position | Beginn |
|---|---|---|
| REPLICEL LIFE SCIENCES INC. | Chief Executive Officer | 28.11.2022 |
| Nolan Olbohrung, LLC | President | - |
| Valence Oil LLC | President | - |
Ehemalige bekannte Positionen von Andrew Schutte
| Unternehmen | Position | Ende |
|---|---|---|
MainPointe Pharmaceuticals LLC
 MainPointe Pharmaceuticals LLC Medical DistributorsDistribution Services MainPointe Pharmaceuticals LLC is a private company based in an undisclosed location, founded by John L. Schutte. The American company specializes in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies to improve patient outcomes and enhance consumer wellness. MainPointe Pharmaceuticals has a management team with more than 50 years of industry experience, established relationships, and superior reputations. The company has a unique access to capital and nimble company structure that makes it unique among similar-sized pharmaceutical companies. Since its launch in 2017, MainPointe Pharmaceuticals has brought nine products to market and is aggressively pursuing new products to bring to market. The company specializes in selling and distributing over-the-counter drugs and supplements. | Chief Tech/Sci/R&D Officer | 01.06.2022 |
| Gerimed, Inc. | Corporate Officer/Principal | 01.02.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REPLICEL LIFE SCIENCES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
MainPointe Pharmaceuticals LLC
MainPointe Pharmaceuticals LLC Medical DistributorsDistribution Services MainPointe Pharmaceuticals LLC is a private company based in an undisclosed location, founded by John L. Schutte. The American company specializes in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies to improve patient outcomes and enhance consumer wellness. MainPointe Pharmaceuticals has a management team with more than 50 years of industry experience, established relationships, and superior reputations. The company has a unique access to capital and nimble company structure that makes it unique among similar-sized pharmaceutical companies. Since its launch in 2017, MainPointe Pharmaceuticals has brought nine products to market and is aggressively pursuing new products to bring to market. The company specializes in selling and distributing over-the-counter drugs and supplements. | Distribution Services |
| Gerimed, Inc. | |
| Nolan Olbohrung, LLC | |
| Valence Oil LLC |
